Stay updated on Inclisiran for CV Event Prevention in Established Disease Clinical Trial
Sign up to get notified when there's something new on the Inclisiran for CV Event Prevention in Established Disease Clinical Trial page.

Latest updates to the Inclisiran for CV Event Prevention in Established Disease Clinical Trial page
- ChecktodayChange DetectedA new revision entry v3.6.5 is added to the history, replacing v3.6.4, indicating a minor update to the page's revision record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new study record version (37, 2026-07-20) adds updates to the Study Status and Contacts/Locations sections and is labeled Revision: v3.6.4; this version follows the previous Revision: v3.6.3 released on 2026-06-11.SummaryDifference0.4%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe latest version entry shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates an updated revision of the study record rather than changes to study data or eligibility.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision tag v3.6.2 is added to the page history, replacing the previous v3.6.0. This indicates a minor update to the page's revision record without changing the study data presented.SummaryDifference0.1%

- Check58 days agoChange DetectedAs of 2026-06-11, the study record shows no longer looking for participants and updates to the Contacts/Locations and Study Status sections, alongside a new revision tag v3.6.0. The previous revision entry dated 2026-05-13 and the older revision (v3.5.5) are removed from the history.SummaryDifference0.6%

- Check65 days agoChange DetectedA new revision entry, v3.5.5, was added to the record history and the previous revision v3.5.4 was removed, signaling an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Inclisiran for CV Event Prevention in Established Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inclisiran for CV Event Prevention in Established Disease Clinical Trial page.